Employing a Highly Potent Fluorescence Probe to Discover a Poly (Adenosine Diphosphate‐ribose) Polymerases‐1/2 Binder and the Complex Structures Analysis
Poly (ADP-ribose) polymerases-1/2 (PARP-1/2) has been identified as important antitumor drug targets and the development of PARP-1/2 inhibitors featuring novel structures is still a promising strategy for cancer treatments. In this work, a highly potent PARP-1/2 probe with a quinazolinone scaffold was designed and synthesized, showing dissociation constants (K<sub>d</sub>) of 2.07 and 1.6 nM toward catPARP-1 and catPARP-2SE, respectively. By employing this probe to screen an in-house compound library, compound A bearing a pyrazolo[1,5-a]pyrimidine-3-carboxamide scaffold is disclosed as a structurally novel PARP-1/2 binder, which has dissociation constants of 5.6 and 7.9 μM for catPARP-1 and catPARP-2SE, respectively, in the isothermal titration calorimetry (ITC) assay. Moreover, the crystal structures of compound A in complex with PARP-1 and PARP-2 catalytic domains are solved to reveal the binding modes of this compound and these two complex structures are analyzed with IGMH method at GFN2-xTB and B3LYP levels. Interestingly, this compound presents significant differences in binding modes within PARP-1 and PARP-2. These results can provide a structural basis for the discovery of novel PARP-1 or PARP-2 selective inhibitors by taking compound A as a template structure.
Authors
- Jinruo Li
- Jie Zhou (ORCID: https://orcid.org/0000-0002-1199-4261)
- Chengyan Wang (ORCID: https://orcid.org/0000-0003-3982-6208)
- Xiaoyu Wang (ORCID: https://orcid.org/0000-0003-2933-7582)
- Bailing Xu (ORCID: https://orcid.org/0000-0003-2633-0887)
Institutions
- Academy of Medical Sciences (GB)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Academia Sinica (TW)
Publication Details
- Journal
- ChemMedChem
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1002/cmdc.202500168
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences